2m 2m 2m 2m 2m 2m 2m
IMMUNOME (IMNM)
NASDAQ
$22.72-$0.08 (-0.35%)
Price as of Jul 13, 2026 7:48 PM EDT- $2.6BMarket Cap
- 167.92%1-Year Change
- BiotechnologyIndustry
IMMUNOME (IMNM)
$22.72-$0.08 (-0.35%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
FMR LLC | 17.75% | 17.0M | +420,238 (+2.48%) | Mar 31, 2026 |
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 17.12% | 16.4M | +2.9M (+17.98%) | Mar 31, 2026 |
BLACKROCK, INC. | 8.55% | 8.2M | +573,678 (+7.02%) | Mar 31, 2026 |
POINT72 ASSET MANAGEMENT, L.P. | 7.36% | 7.0M | +2.2M (+31.42%) | Dec 31, 2025 |
VANGUARD GROUP INC | 6.32% | 6.0M | +1.1M (+18.96%) | Dec 31, 2025 |
REDMILE GROUP, LLC | 5.82% | 5.6M | -159,500 (-2.87%) | Mar 31, 2026 |
STATE STREET CORP | 5.65% | 5.4M | +1.5M (+28.37%) | Mar 31, 2026 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
FIDELITY MT VERNON STREET TRUST | 7.37% | 7.0M | +857,381 (+12.17%) | Feb 28, 2026 |
T. Rowe Price Small-Cap Stock Fund, Inc. | 6.03% | 5.8M | +636,968 (+11.05%) | Mar 31, 2026 |
VANGUARD INDEX FUNDS | 4.52% | 4.3M | +77,191 (+1.79%) | Mar 31, 2026 |
PRIMECAP Odyssey Funds | 4.05% | 3.9M | +10,000 (+0.26%) | Apr 30, 2026 |
T. Rowe Price Equity Funds, Inc. | 3.26% | 3.1M | +337,862 (+10.84%) | Mar 31, 2026 |
SPDR SERIES TRUST | 3.07% | 2.9M | 0 (0.00%) | Apr 30, 2026 |
VANGUARD SPECIALIZED FUNDS | 2.90% | 2.8M | +818,439 (+29.48%) | Apr 30, 2026 |
Current Ownership Distribution
- Institutions708.0M (76.60%)
- Mutual Funds211.7M (22.90%)
- Insiders4.6M (0.50%)
- Other0 (0.00%)
Insider Transactions
- 0.50% (4.6M)Current InsiderOwnership (%, shares)
- 3Number of InsiderBuying (last 12 months)
- $33.6MAmount of InsiderBuying (last 12 months)
- 5Number of InsiderSelling (last 12 months)
- $96.3MAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Horn Kinney CHIEF BUSINESS OFFICER | Exempt | Jul 07, 2026 | $0.00 | 1,092 | $0.00 | 128,908 |
Horn Kinney CHIEF BUSINESS OFFICER | Exempt | Jul 07, 2026 | $14,108.64 | 1,092 | $12.92 | 1,092 |
Horn Kinney CHIEF BUSINESS OFFICER | Sell | Jul 07, 2026 | $27,300.00 | 1,092 | $25.00 | 0 |
Barchas Isaac | Sell | Jul 02, 2026 | $1.7M | 75,665 | $22.35 | 232,839 |
Lechleider Robert Chief Medical Officer | Exempt | Jul 02, 2026 | $0.00 | 55,000 | $0.00 | 290,000 |
Barchas Isaac | Sell | Jul 02, 2026 | $567,735.55 | 24,335 | $23.33 | 208,504 |
Lechleider Robert Chief Medical Officer | Exempt | Jul 02, 2026 | $480,150.00 | 55,000 | $8.73 | 70,805 |
Lechleider Robert Chief Medical Officer | Sell | Jul 02, 2026 | $498,572.30 | 22,714 | $21.95 | 48,091 |
Lechleider Robert Chief Medical Officer | Sell | Jul 02, 2026 | $369,030.64 | 16,214 | $22.76 | 31,877 |
Lechleider Robert Chief Medical Officer | Sell | Jul 02, 2026 | $376,727.68 | 16,072 | $23.44 | 15,805 |
Barchas Isaac | Sell | Jun 30, 2026 | $2.1M | 101,050 | $21.12 | 308,504 |
Rosett Max Chief Financial Officer | Exempt | Jun 15, 2026 | $0.00 | 60,000 | $0.00 | 0 |
Rosett Max Chief Financial Officer | Exempt | Jun 15, 2026 | $63,000.00 | 60,000 | $1.05 | 114,037 |
Rosett Max Chief Financial Officer | Sell | Jun 15, 2026 | $1.1M | 60,000 | $18.23 | 54,037 |
SCHAFER CAROL | Award | Jun 10, 2026 | $0.00 | 9,897 | $0.00 | 9,897 |
WAGENHEIM PHILIP | Award | Jun 10, 2026 | $0.00 | 9,897 | $0.00 | 9,897 |
Boylan James P | Award | Jun 10, 2026 | $0.00 | 9,897 | $0.00 | 9,897 |
SWAIN SANDRA M | Award | Jun 10, 2026 | $0.00 | 9,897 | $0.00 | 9,897 |
Barchas Isaac | Award | Jun 10, 2026 | $0.00 | 9,897 | $0.00 | 9,897 |
Rosett Max Chief Financial Officer | Exempt | Apr 02, 2026 | $0.00 | 31,848 | $0.00 | 60,000 |
Higgins Jack Chief Scientific Officer | Sell | Apr 02, 2026 | $204,238.32 | 9,438 | $21.64 | 22,000 |
Rosett Max Chief Financial Officer | Exempt | Apr 02, 2026 | $0.00 | 39,713 | $0.00 | 0 |
Rosett Max Chief Financial Officer | Exempt | Apr 02, 2026 | $33,440.40 | 31,848 | $1.05 | 79,324 |
Rosett Max Chief Financial Officer | Exempt | Apr 02, 2026 | $53,612.55 | 39,713 | $1.35 | 119,037 |
Rosett Max Chief Financial Officer | Sell | Apr 02, 2026 | $1.4M | 63,656 | $21.91 | 55,381 |
Rosett Max Chief Financial Officer | Sell | Apr 02, 2026 | $30,213.12 | 1,344 | $22.48 | 54,037 |
BIENAIME JEAN JACQUES | Buy | Mar 11, 2026 | $21,550.00 | 1,000 | $21.55 | 38,415 |
BIENAIME JEAN JACQUES | Buy | Mar 10, 2026 | $22,120.00 | 1,000 | $22.12 | 37,415 |
SIEGALL CLAY B President and CEO | Buy | Dec 30, 2025 | $100,018.35 | 4,729 | $21.15 | 665,254 |
Barchas Isaac | Sell | Dec 22, 2025 | $8.1M | 371,949 | $21.72 | 2.0M |